Conmed Corp (CNMD)
80.91
+3.13 (+4.02%)
USD |
NYSE |
Sep 28, 16:00
80.91
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.465B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -40.34% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.520 |
| Price to Book Value | 3.663 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.20 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 1.460 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 65.69% |
News
Headline
Wire
Time (ET)
Yahoo
09/06 16:05
Yahoo
08/02 13:53
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 10/27/2022* | -- | Results | Q3 2022 | -- | 0.76 | -- | |
| 10/27/2022* | 16:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 07/27/2022 | 16:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 07/27/2022 | -- | Results | Q2 2022 | 0.76 | 0.75 | 1.80% | |
| 05/04/2022 | -- | Results | Q1 2022 | 0.70 | 0.62 | 13.18% | |
| 05/04/2022 | 16:30 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 01/26/2022 | -- | Results | Q4 2021 | 1.07 | 1.03 | 4.13% | |
| 01/26/2022 | 16:30 EST | Earnings Call | Q4 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%. |
| URL | https://www.conmed.com |
| Investor Relations URL | https://www.conmed.com/en-US/Investor-Relations |
| HQ State/Province | Florida |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Oct. 27, 2022 (est.) |
| Last Earnings Release | Jul. 27, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 14, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.80 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.7188 |
| Yield to Sector | 0.5542 |
| Yield to Industry | 0.5849 |
| Last Dividend Amt. | 0.20 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Sep. 14, 2022 |
| Yield (TTM) | 0.99% |
| Forward Yield | 1.03% |
| Payout Ratio | -20.58% |
| Cash Payout Ratio | 41.82% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of September 27, 2022.
Fundamentals
| Revenue (TTM) | 1.042B |
| Total Expenses (TTM) | 931.48M |
| Net Income (TTM) | -113.92M |
| Total Assets (Quarterly) | 2.072B |
| Total Liabilities (Quarterly) | 1.399B |
| Shareholders Equity (Quarterly) | 672.97M |
| Cash from Operations (TTM) | 74.22M |
| Cash from Investing (TTM) | -160.72M |
| Cash from Financing (TTM) | 96.03M |
Ratings
Profile
Edit
| Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%. |
| URL | https://www.conmed.com |
| Investor Relations URL | https://www.conmed.com/en-US/Investor-Relations |
| HQ State/Province | Florida |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Oct. 27, 2022 (est.) |
| Last Earnings Release | Jul. 27, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 14, 2022 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| CNMD Tweets |